| People | Locations | Statistics |
|---|---|---|
| Naji, M. |
| |
| Motta, Antonella |
| |
| Aletan, Dirar |
| |
| Mohamed, Tarek |
| |
| Ertürk, Emre |
| |
| Taccardi, Nicola |
| |
| Kononenko, Denys |
| |
| Petrov, R. H. | Madrid |
|
| Alshaaer, Mazen | Brussels |
|
| Bih, L. |
| |
| Casati, R. |
| |
| Muller, Hermance |
| |
| Kočí, Jan | Prague |
|
| Šuljagić, Marija |
| |
| Kalteremidou, Kalliopi-Artemi | Brussels |
|
| Azam, Siraj |
| |
| Ospanova, Alyiya |
| |
| Blanpain, Bart |
| |
| Ali, M. A. |
| |
| Popa, V. |
| |
| Rančić, M. |
| |
| Ollier, Nadège |
| |
| Azevedo, Nuno Monteiro |
| |
| Landes, Michael |
| |
| Rignanese, Gian-Marco |
|
Muhammad, Sohail
in Cooperation with on an Cooperation-Score of 37%
Topics
Publications (3/3 displayed)
- 2021Bioglass-fibre reinforced hydroxyapatite composites synthesized using spark plasma sintering for bone tissue engineeringcitations
- 2018Low Temperature Synthesis of Anatase TiO2 Nanoparticles and its Application in Nanocrystalline Thin Films
- 2018Removal of Heavy Metals (Lead, Cadmium and Iron) from Low-Grade Nanoscale Zinc Oxide Using Ammonium Carbonate Solution as a Leaching Agent
Places of action
| Organizations | Location | People |
|---|
article
Bioglass-fibre reinforced hydroxyapatite composites synthesized using spark plasma sintering for bone tissue engineering
Abstract
<jats:p>Hydroxyapatite (HA) exhibits several desirable characteristics, but it stilllacks osteoinduction, which is a necessary requirement for a bone scaffold.HA-based composites with different amounts of Bioglass? (BG) were preparedusing spark plasma sintering (SPS). Careful selection of the SPS parametersavoided undesirable reactions between the calcium phosphate (CaP) andbioglass (BG present in the form of powder and fibres), as confirmed throughX-ray diffraction analysis. Scanning electron microscopy images of thecomposite scaffolds revealed a fibre like appearance of the glassy region.The in vitro bioactivity and biodegradation analyses were performed byimmersing the composites in simulated body fluid (SBF) andtris(hydroxymethyl)aminomethane (Tris), respectively. The ability to obtainonly the CaP phase and glassy phase with desirable bioactive andbiodegradation behaviour, indicated that these SPS scaffolds can be employedas bone scaffolds for clinical trials, after further in vivo analyses.</jats:p>